BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18618485)

  • 1. Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation.
    Fridrich D; Teller N; Esselen M; Pahlke G; Marko D
    Mol Nutr Food Res; 2008 Jul; 52(7):815-22. PubMed ID: 18618485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delphinidin inhibits a broad spectrum of receptor tyrosine kinases of the ErbB and VEGFR family.
    Teller N; Thiele W; Boettler U; Sleeman J; Marko D
    Mol Nutr Food Res; 2009 Sep; 53(9):1075-83. PubMed ID: 19653223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
    Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
    Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH; Song YC; Kim SH; Jo H; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of the epidermal growth factor receptor in apple juice extract.
    Kern M; Tjaden Z; Ngiewih Y; Puppel N; Will F; Dietrich H; Pahlke G; Marko D
    Mol Nutr Food Res; 2005 Apr; 49(4):317-28. PubMed ID: 15759309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the biological activities of methylated derivatives of (-)-epigallocatechin-3-O-gallate (EGCG) and their cell surface binding activities.
    Yano S; Fujimura Y; Umeda D; Miyase T; Yamada K; Tachibana H
    J Agric Food Chem; 2007 Aug; 55(17):7144-8. PubMed ID: 17661493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells.
    Grunt TW; Wagner R; Grusch M; Berger W; Singer CF; Marian B; Zielinski CC; Lupu R
    Biochem Biophys Res Commun; 2009 Jul; 385(3):454-9. PubMed ID: 19467222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkynyl pyrimidines as dual EGFR/ErbB2 kinase inhibitors.
    Waterson AG; Stevens KL; Reno MJ; Zhang YM; Boros EE; Bouvier F; Rastagar A; Uehling DE; Dickerson SH; Reep B; McDonald OB; Wood ER; Rusnak DW; Alligood KJ; Rudolph SK
    Bioorg Med Chem Lett; 2006 May; 16(9):2419-22. PubMed ID: 16483772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidermal growth factor receptor and human topoisomerases represent potential cellular targets of oligomeric procyanidins.
    Fridrich D; Kern M; Fritz J; Pahlke G; Köhler N; Winterhalter P; Marko D
    Mol Nutr Food Res; 2007 Feb; 51(2):192-200. PubMed ID: 17230588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K; Shin-ya T; Nishio K; Ito F
    FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin in pigmented fruits and vegetables.
    Afaq F; Zaman N; Khan N; Syed DN; Sarfaraz S; Zaid MA; Mukhtar H
    Int J Cancer; 2008 Oct; 123(7):1508-15. PubMed ID: 18623129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The substitution pattern of anthocyanidins affects different cellular signaling cascades regulating cell proliferation.
    Marko D; Puppel N; Tjaden Z; Jakobs S; Pahlke G
    Mol Nutr Food Res; 2004 Sep; 48(4):318-25. PubMed ID: 15497183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells.
    Adachi S; Shimizu M; Shirakami Y; Yamauchi J; Natsume H; Matsushima-Nishiwaki R; To S; Weinstein IB; Moriwaki H; Kozawa O
    Carcinogenesis; 2009 Sep; 30(9):1544-52. PubMed ID: 19578043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combi-targeting concept: synthesis of stable nitrosoureas designed to inhibit the epidermal growth factor receptor (EGFR).
    Domarkas J; Dudouit F; Williams C; Qiyu Q; Banerjee R; Brahimi F; Jean-Claude BJ
    J Med Chem; 2006 Jun; 49(12):3544-52. PubMed ID: 16759097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
    Barlaam B; Acton DG; Ballard P; Bradbury RH; Cross D; Ducray R; Germain H; Hudson K; Klinowska T; Magnien F; Ogilvie DJ; Olivier A; Ross HS; Smith R; Trigwell CB; Vautier M; Wright L
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1799-803. PubMed ID: 18313293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells.
    Kawaguchi K; Murakami H; Taniguchi T; Fujii M; Kawata S; Fukui T; Kondo Y; Osada H; Usami N; Yokoi K; Ueda Y; Yatabe Y; Ito M; Horio Y; Hida T; Sekido Y
    Carcinogenesis; 2009 Jul; 30(7):1097-105. PubMed ID: 19380521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.
    Pignon JC; Koopmansch B; Nolens G; Delacroix L; Waltregny D; Winkler R
    Cancer Res; 2009 Apr; 69(7):2941-9. PubMed ID: 19318561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
    Wang CY; Wang YT; Tzeng DW; Yang JL
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 67kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCG.
    Fujimura Y; Umeda D; Yano S; Maeda-Yamamoto M; Yamada K; Tachibana H
    Biochem Biophys Res Commun; 2007 Dec; 364(1):79-85. PubMed ID: 17927962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.